US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Simvastatin 40 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0060-01 D-0503-2023
Class II · Moderate risk Terminated

Rosuvastatin 40mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1311-01 D-0502-2023
Class II · Moderate risk Terminated

Rosuvastatin 10mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0375-03 D-0501-2023
Class II · Moderate risk Terminated

Rosuvastatin 5mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-3519-00 D-0500-2023
Class II · Moderate risk Terminated

Ropinirole 2mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2750-00 D-0499-2023
Class II · Moderate risk Terminated

Atorvastatin 20 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1977-00 D-0498-2023
Class II · Moderate risk Terminated

Tadalafil 5 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2972-00 D-0497-2023
Class II · Moderate risk Terminated

Simvastatin 10 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0064-01 D-0496-2023
Class II · Moderate risk Terminated

Rosuvastatin 5mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-3519-00 D-0495-2023
Class II · Moderate risk Terminated

Ropinirole 0.5 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2439-00 D-0494-2023
Class II · Moderate risk Terminated

Glimepiride 2 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-0405-03 D-0493-2023
Class II · Moderate risk Terminated

Doxazosin 2 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1560-00 D-0492-2023
Class II · Moderate risk Terminated

Atorvastatin 10 mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-1946-00 D-0491-2023
Class II · Moderate risk Terminated

Aripiprazole 5mg tablets

Reason cGMP Deviations

RemedyRepack Inc. NDC 70518-2921-03 D-0490-2023
Class II · Moderate risk Terminated

Glimepiride Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Amerisource Health Services LLC NDC 68001-179-00 D-0759-2023
Class II · Moderate risk Terminated

Glimepiride Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Amerisource Health Services LLC NDC 68001-178-00 D-0758-2023
Class II · Moderate risk Terminated

Glimepiride Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Amerisource Health Services LLC NDC 68001-177-00 D-0757-2023
Class II · Moderate risk Terminated

Verapamil Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specifications: Out of specification dissolution results above specified values.

Amerisource Health Services LLC D-0536-2023
Class II · Moderate risk Terminated

Simvastatin

Reason cGMP deviations

Direct Rx NDC 61919-0431-90 D-0486-2023
Class II · Moderate risk Terminated

Simvastatin

Reason cGMP deviations

Direct Rx NDC 61919-0446-30 D-0485-2023
Class II · Moderate risk Terminated

Simvastatin

Reason cGMP deviations

Direct Rx NDC 61919-0688-30 D-0484-2023
Class II · Moderate risk Terminated

Simvastatin

Reason cGMP deviations

Direct Rx NDC 61919-0710-90 D-0483-2023
Class II · Moderate risk Terminated

Glimepiride

Reason cGMP deviations

Direct Rx NDC 61919-0250-30 D-0482-2023
Class II · Moderate risk Terminated

Glimepiride

Reason cGMP deviations

Direct Rx NDC 61919-0488-30 D-0481-2023
Class II · Moderate risk Terminated

Glimepiride

Reason cGMP deviations

Direct Rx NDC 61919-0723-30 D-0480-2023